Brian Baker joined Turning Point Therapeutics in July 2017 to establish the company’s finance and administration organization. He is a licensed CPA with more than two decades of senior accounting and finance experience, primarily with emerging biotechnology companies. He gained “Big Four” public accounting experience during his tenure at PricewaterhouseCoopers (PwC), where he was a senior assurance advisor. In addition to PwC, Mr. Baker held senior financial positions with Cleave Biosciences, Phenomix Corporation and Cengent Therapeutics. He has significant fundraising experience in excess of $200 million in equity and $35 million in venture debt. Mr. Baker earned both a Master of Science in business administration, information systems and a Bachelor of Science in business administration, accounting from San Diego State University.